353 related articles for article (PubMed ID: 19779719)
1. The pathological spectrum of CNS inflammatory demyelinating diseases.
Hu W; Lucchinetti CF
Semin Immunopathol; 2009 Nov; 31(4):439-53. PubMed ID: 19779719
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic inflammatory-demyelinating diseases of the central nervous system.
Cañellas AR; Gols AR; Izquierdo JR; Subirana MT; Gairin XM
Neuroradiology; 2007 May; 49(5):393-409. PubMed ID: 17333161
[TBL] [Abstract][Full Text] [Related]
3. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
Karussis D
J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
[TBL] [Abstract][Full Text] [Related]
5. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
7. Pathology of demyelinating diseases.
Popescu BF; Lucchinetti CF
Annu Rev Pathol; 2012; 7():185-217. PubMed ID: 22313379
[TBL] [Abstract][Full Text] [Related]
8. Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.
Lucchinetti C
Curr Top Microbiol Immunol; 2008; 318():19-43. PubMed ID: 18219813
[TBL] [Abstract][Full Text] [Related]
9. Acquired inflammatory white matter disease.
Gallucci M; Caulo M; Cerone G; Masciocchi C
Childs Nerv Syst; 2001 Apr; 17(4-5):202-10. PubMed ID: 11398938
[TBL] [Abstract][Full Text] [Related]
10. Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome.
Hardy TA
Curr Opin Neurol; 2019 Jun; 32(3):467-474. PubMed ID: 30844860
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic criteria of borderline forms of multiple sclerosis].
Dupel-Pottier C
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):935-43. PubMed ID: 11787358
[TBL] [Abstract][Full Text] [Related]
12. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
Frederick MC; Cameron MH
Curr Neurol Neurosci Rep; 2016 Mar; 16(3):26. PubMed ID: 26847090
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
14. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
Wegner C
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
[TBL] [Abstract][Full Text] [Related]
16. Atypical inflammatory demyelinating syndromes of the CNS.
Hardy TA; Reddel SW; Barnett MH; Palace J; Lucchinetti CF; Weinshenker BG
Lancet Neurol; 2016 Aug; 15(9):967-981. PubMed ID: 27478954
[TBL] [Abstract][Full Text] [Related]
17. The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports.
Bellinvia A; Pastò L; Razzolini L; Fratangelo R; Prestipino E; Fonderico M; Tudisco L; Amato MP
Mult Scler Relat Disord; 2019 Aug; 33():51-54. PubMed ID: 31152967
[TBL] [Abstract][Full Text] [Related]
18. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
Kutzelnigg A; Lassmann H
Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
[TBL] [Abstract][Full Text] [Related]
19. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
20. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
